Department of Orthopaedic surgery, Fukuoka Shion Hospital, Ogori-shi, Japan.
Department of Orthopaedic surgery, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka-shi, Japan.
Mod Rheumatol Case Rep. 2020 Jul;4(2):171-175. doi: 10.1080/24725625.2020.1739194. Epub 2020 Mar 13.
Osteoarticular tuberculosis can occur in patients with rheumatoid arthritis (RA) receiving immunosuppressive therapy. Here, we describe a case of tubercular osteomyelitis in an old fused hip of a patient with RA who received prednisolone, salazosulfapyridine (SASP), and low-dose methotrexate (MTX). A 77-year-old man with a 4-year history of RA was admitted with a complaint of general fatigue. His symptoms of RA had been well controlled with a combination of prednisolone, SASP, and low-dose MTX. Because the laboratory data showed an increase in serum C-reactive protein levels, we suspected pneumonia. There was expansion of a pre-existing consolidation in the right lower lobe of his lung on chest computed tomography, and the sputum culture was positive for . His family physician prescribed empiric antibiotics for pneumonia. Although the QuantiFERON test result was positive, the acid-fast bacillus staining result was negative in the sputum. He started complaining of pain in his left hip, where arthrodesis was performed for an unknown reason at the age of 20 years. Sonographic examination of his left thigh revealed fluid collection. The aspiration culture of the fluid was positive for . He was initiated on rifampicin, isoniazid, pyrazinamide, and ethambutol. Surgical debridement of the fused left hip was performed twice along with a removal of previously implanted materials. Although infrequent, osteoarticular tuberculosis can occur during immunosuppressive therapy, especially in elderly patients. Physicians should be aware of a history of possible tuberculosis infection, such as hip arthrodesis, when prescribing MTX along with SASP and corticosteroid in the elderly.
在接受免疫抑制治疗的类风湿关节炎 (RA) 患者中可能发生骨关节结核。在这里,我们描述了 1 例在接受泼尼松龙、柳氮磺胺吡啶 (SASP) 和低剂量甲氨蝶呤 (MTX) 治疗的 RA 老年融合髋关节患者中发生的结核性骨髓炎病例。1 名 77 岁男性,RA 病史 4 年,因全身乏力就诊。他的 RA 症状通过泼尼松龙、SASP 和低剂量 MTX 的联合治疗得到了很好的控制。由于实验室数据显示血清 C 反应蛋白水平升高,我们怀疑是肺炎。胸部计算机断层扫描显示他的右下肺有一个先前存在的实变区扩大,痰培养阳性。他的家庭医生开了经验性抗生素治疗肺炎。尽管 QuantiFERON 检测结果阳性,但痰中抗酸杆菌染色结果为阴性。他开始抱怨左髋疼痛,20 岁时因不明原因进行了髋关节融合术。左大腿的超声检查显示有积液。液体的抽吸培养阳性。他开始接受利福平、异烟肼、吡嗪酰胺和乙胺丁醇治疗。融合的左髋关节进行了两次清创手术,并取出了先前植入的材料。虽然不常见,但在免疫抑制治疗期间,尤其是在老年患者中,可能会发生骨关节结核。当在老年患者中同时开具 MTX、SASP 和皮质类固醇时,医生应注意髋关节融合等可能的结核感染史。